IRIS
LATRONICO, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.770
AS - Asia 1.289
EU - Europa 1.021
SA - Sud America 337
AF - Africa 82
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.720
SG - Singapore 542
CN - Cina 369
BR - Brasile 296
IT - Italia 228
SE - Svezia 195
HK - Hong Kong 194
RU - Federazione Russa 133
DE - Germania 114
UA - Ucraina 71
VN - Vietnam 71
FI - Finlandia 69
GB - Regno Unito 59
CI - Costa d'Avorio 55
FR - Francia 49
CA - Canada 32
IN - India 24
BE - Belgio 18
PL - Polonia 15
AR - Argentina 14
NL - Olanda 14
ID - Indonesia 13
ZA - Sudafrica 12
AT - Austria 10
ES - Italia 10
IE - Irlanda 10
MX - Messico 10
BD - Bangladesh 9
JP - Giappone 9
TR - Turchia 9
CZ - Repubblica Ceca 8
IQ - Iraq 8
LT - Lituania 8
VE - Venezuela 8
AU - Australia 7
AE - Emirati Arabi Uniti 4
CO - Colombia 4
JO - Giordania 4
SA - Arabia Saudita 4
TN - Tunisia 4
CL - Cile 3
DZ - Algeria 3
EC - Ecuador 3
IL - Israele 3
IR - Iran 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CR - Costa Rica 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.508
Salva come PNG Salva come JPEG
Città #
Ashburn 331
Woodbridge 264
Chandler 258
Singapore 254
Fairfield 214
Hong Kong 191
Houston 167
Nyköping 160
Jacksonville 145
Ann Arbor 143
Beijing 123
Wilmington 100
Seattle 89
Cambridge 85
Bari 70
Abidjan 55
New York 53
Lawrence 49
Roxbury 47
Nanjing 37
Los Angeles 35
Marseille 33
Boardman 31
Dallas 31
Ho Chi Minh City 28
Des Moines 26
Munich 26
São Paulo 25
Turku 21
Brooklyn 19
Brussels 17
Jiaxing 16
Chicago 15
Moscow 15
Santa Clara 15
Spongano 15
Hanoi 14
Rio de Janeiro 14
Guangzhou 13
Jakarta 13
Leverano 13
Princeton 13
Denver 12
Inglewood 12
Toronto 12
Warsaw 12
Wuhan 12
Changsha 11
Falls Church 11
Grottaglie 11
San Diego 11
Dublin 10
Shenyang 10
Amsterdam 9
Buffalo 9
London 9
San Francisco 9
Shanghai 9
Vienna 9
Hebei 8
Helsinki 8
Nuremberg 8
Porto Alegre 8
Tianjin 8
Atlanta 7
Auburn Hills 7
Council Bluffs 7
Falkenstein 7
Montreal 7
Nanchang 7
Palermo 7
Rome 7
Salvador 7
Belo Horizonte 6
Boston 6
Chennai 6
Frankfurt am Main 6
Johannesburg 6
Orem 6
Paris 6
Tokyo 6
Adelfia 5
Brno 5
Da Nang 5
Giovinazzo 5
Manaus 5
Poplar 5
Scottsdale 5
Sydney 5
Amman 4
Baghdad 4
Campinas 4
Dearborn 4
Naples 4
Ottawa 4
Stockholm 4
São Bernardo do Campo 4
Washington 4
Wuxi 4
Zhengzhou 4
Totale 3.696
Salva come PNG Salva come JPEG
Nome #
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 217
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 166
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 165
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 152
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 133
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 128
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 126
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 116
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 115
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 115
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 112
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 110
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 109
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 103
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 101
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 98
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 92
null 91
null 90
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 90
High surface area mesoporous silica nanoparticles with tunable size in the sub-micrometer regime: Insights on the size and porosity control mechanisms 90
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies 90
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 88
null 87
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 87
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 86
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 85
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 84
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 82
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 81
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 80
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 80
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 80
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 79
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 77
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 77
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 76
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 72
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 72
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 71
Matrix Metalloproteinases in CNS Inflammation. 70
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 70
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 69
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 68
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 67
Differential Modulation of NF-κ B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules 64
DEVELOPMENTAL OMEGA-3 SUPPLEMENTATION IMPROVES MOTOR SKILLS IN JUVENILE RATS 64
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 62
Antioxidant Activity of Polysaccharides from the Edible Mushroom Pleurotus eryngii 60
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 58
Unravelling the relevance of fad synthetase in human physiopathology. A biotechnological approach. 55
Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 54
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality 52
Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation 49
Resveratrol impinges on retrograde communication without inducing mitochondrial biogenesis in aged rat soleus muscle 48
null 47
Interferon-alpha/beta treatment inhibits metalloproteinase activity in rat astrocyte cell cultures 46
Inhibition of calpain activity and expression by interferon-beta in rat astrocytes: implications for MS pathogenesis and treatment. 45
Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves 43
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19 43
Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an “In Vivo” Model of Neurotoxicity 42
Interferon-Beta Treatment Inhibits Matrix metalloproteinases in rat glial cell cultures 41
Intra- and interspecific variation in electrophoretic profiles of Tethya spp.: an integration to morfological classification system 38
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 38
Inhibitory effect of immunomodulatory and immunosuppressive therapies on the activity of gelatinases and urokinase-type plasminogen activator in peripheral blood mononuclear cells from patients with multiple sclerosis 33
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia 30
Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the "Normobaric Oxygen Paradox" 29
Lead exposure of rats during and after pregnancy induces anti-myelin proteolytic activity: a potential mechanism for lead-induced neurotoxicity 29
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects 26
Use of a commercial feed supplement based on diatom earth and yeast products on oxidative status and in vitro immune response in buffaloes during peripartum 25
Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species 25
Molecular mechanisms of cell toxicity and Matrix Metalloproteinase-9 inhibition by Antiretroviral Drugs in Cultured Primary Astrocytes. 22
Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives 21
Enhancing Antioxidants Performance of Ceria Nanoparticles in Biological Environment via Surface Engineering with o-Quinone Functionalities 18
null 18
null 15
Inhibition of MMP-2 and MMP-9 by Dietary Antioxidants in THP-1 Macrophages and Sera from Patients with Breast Cancer 13
Increased Antioxidant Performance of Lignin by Biodegradation Obtained from an Extract of the Mushroom Pleurotus eryngii 13
Reliable New Biomarkers of Mitochondrial Oxidative Stress and Neuroinflammation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients: A Pilot Study 12
Totale 5.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 12 33 34 48 66 42 12
2021/2022373 10 51 2 5 19 24 12 20 49 29 54 98
2022/2023752 77 79 53 68 86 96 9 91 131 33 15 14
2023/2024281 17 49 13 60 23 63 4 2 5 11 6 28
2024/20251.254 111 29 72 34 44 72 158 95 54 70 167 348
2025/20261.386 377 160 173 263 308 105 0 0 0 0 0 0
Totale 5.675